The rare species of Ebola involved - known as Bundibugyo - kills around a third of those infected and has no proven vaccine ...

British scientists are developing a new Ebola vaccine using the same technology behind the AstraZeneca Covid-19 jab to help ...

Pancreatic cancer has long been oncology’s most stubborn adversary. Fewer than 13% of patients survive five years after ...

Tests with rodents suggest an mRNA vaccine in development offers protection against three strains of Ebola virus, including the one behind the current crisis ...

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.

A decade after Ebola vaccines changed outbreak response, a new epidemic in central Africa is caused by a strain the world ...

UH engineers helped develop an mRNA-based strategy that boosts cancer-fighting T cells and, in mouse studies, helped ...

Scientists at La Jolla Institute for Immunology (LJI) have discovered that combining key vaccine ingredients could give the ...

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein ...

The anticipated rollout of updated Covid vaccines this fall might be at risk after a change by Health and Human Services Secretary Robert F. Kennedy Jr. in how vaccines are tested, experts say. Under ...

The following companies are leading this vector-borne boon, each tackling the problem from a different technological angle: ...

The CDC's stance on vaccination has drastically changed, which may be behind people's dipping trust in immunizations, according to new research.